The expression of WT1‐AS is abnormally elevated in CRC, acute myelocytic leukemia, Wilms tumor, and breast cancer, while is downregulated in gastric cancer, liver cancer, cervical cancer, and kidney cancer.46 This evidence concerns the gene WT1 and breast carcinoma.